Objective: Ciprofloxacin resistance has been reported in 4.5% of patients with otorrhea and is increasing in prevalence. Due to ototoxicity, only fluoroquinolones are Food and Drug Administration approved for topical therapy in the middle ear. Furthermore, there is an assumption that antibiotic resistance is less relevant to topical therapy due to in vivo concentrations much higher than the minimum inhibitory concentration used to determine resistance. This study investigates ciprofloxacin-resistant infections and seeks to develop a better understanding of treatment options and outcomes.

Study Design: Retrospective review of 141 ciprofloxacin-resistant otologic infections.

Setting: Tertiary-care hospital.

Patients: Patients with culture-proven ciprofloxacin-resistant infections from 2008 to 2017.

Intervention(s): Antibiotic treatment with ciprofloxacin topical drops, ciprofloxacin plus oral antibiotics, and nonciprofloxacin therapy.

Main Outcome Measure(s): Bacteriology for ciprofloxacin-resistant infections and treatment effectiveness of various therapies.

Results: Methicillin-resistant Staphylococcus aureus (33%), Corynebacterium striatum (19%), and non-Methicillin-resistant Staphylococcus aureus (11%) are the most frequent causes of ciprofloxacin-resistant infections. Topical ciprofloxacin monotherapy was successful in 2.7% of infections compared with a 64.7% success rate with the addition of an oral antibiotic (p < 0.001). Nonciprofloxacin drops are more effective with a 70% cure rate compared with the 2.7% of the ciprofloxacin drops p < 0.001. There was no difference in treatment efficacy when comparing nonciprofloxacin topical therapy (70% cure) to nonciprofloxacin topical therapy plus oral antibiotic (83% cure, p = 0.17).

Conclusions: Using ciprofloxacin drops to treat ciprofloxacin-resistant bacteria is ineffective and patients do significantly better with alternative therapy. This finding supports the conclusion that high concentrations achieved in topical applications are not sufficient to overcome antibiotic resistance.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0000000000001966DOI Listing

Publication Analysis

Top Keywords

ciprofloxacin-resistant infections
16
topical therapy
8
staphylococcus aureus
8
infections
6
ciprofloxacin-resistant
5
treatment
4
treatment ciprofloxacin-resistant
4
ciprofloxacin-resistant ear
4
ear infections
4
infections objective
4

Similar Publications

Article Synopsis
  • Fluroquinolone resistance in Enterobacteriaceae, including Proteus, poses a significant public health threat, particularly affecting treatments for UTIs and intra-abdominal infections.
  • The study aimed to identify specific quinolone resistance genes in ciprofloxacin-resistant Proteus species within a defined timeframe and location in Bangladesh.
  • Results showed a high prevalence (64.58%) of plasmid-mediated quinolone resistance genes among resistant isolates, indicating a concerning trend that could lead to increased resistance and transmission due to over-prescription of fluoroquinolones.
View Article and Find Full Text PDF

: The use of antimicrobials to treat food animals leaves antimicrobial residues in foodstuffs. The World Health Organization (WHO) defines the acceptable daily intakes (ADIs) of these residues as the dose of these antimicrobials that is safe for an average human to consume on a daily basis. We hypothesized that the lowest dose of ciprofloxacin classified as safe by the WHO could select for ciprofloxacin-resistant strains of in a model.

View Article and Find Full Text PDF
Article Synopsis
  • Infections caused by pathogens like gonorrhea can present similar clinical symptoms, leading to common treatments that may increase antibiotic resistance.
  • Certest Biotec created two diagnostic kits for the simultaneous detection of gonorrhea and fluoroquinolone resistance, showing promising performance in a clinical study.
  • The study analyzed 540 clinical samples, revealing high sensitivity and specificity of the kits compared to traditional diagnostic methods, enhancing diagnosis and treatment while addressing rising antibiotic resistance.
View Article and Find Full Text PDF

The surge in multidrug resistance in Staphylococcus aureus is the pressing need to identify novel alternatives to combat antimicrobial resistance effectively. Bakuchiol is a bioactive prenylated phenolic meroterpene largely abundant in the seeds of Psoralea corylifolia. In this study, we present the biological assessment of bakuchiol derived from P.

View Article and Find Full Text PDF

Combining with matrine restores ciprofloxacin efficacy against qnrS producing E. coli in vitro and in vivo.

Microb Pathog

January 2025

Chinese Veterinary Medicine Innovation Center, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China; National Center of Technology Innovation for Medicinal Function of Food, National Food and Strategic Reserves Administration, Beijing, 100193, China. Electronic address:

The exposure risk of plasmid-mediated quinolone resistance (PMQR) genes increases the incidence of resistant bacterial infections, has resulted in clinical treatment failures with ciprofloxacin, necessitating urgent implementation of novel strategies for controlling this situation. Matrine serves as the principal constituent of the traditional Chinese herb Sophora flavescens Ait. and exhibits pharmacological activities including anti-inflammatory, antibacterial, anti-tumor, and hepatoprotective effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!